Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onzetra Xsail in adolescent migraine
NCT03338920Phase 3Terminated
- Sponsor
- Currax Pharmaceuticals LLC
- Start
- Nov 2017
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sumatriptan in migraine, sponsored by Currax Pharmaceuticals LLC. Started Nov 2017; status: terminated.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03338920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03338920.